...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Don must be happy

It is nice to see ZE seemimgly making scientific progress and building realtionships with various BPs.

Seems like Dr Lakhotia is making steady progress. It would be great to see the key business issues addressed at some point but I'm not expecting that from ZCC University.

I hope that Don stays preoccupied with his mess at RVX so that he doesn't interfer with the ZE progress.

GLTA

Toinv

 

Share
New Message
Please login to post a reply